# Dexcel Pharma Technologies Ltd.

Dexcel Pharma Technologies Ltd. is a Private Company based in New York, United States.

## Overview

- **Organization type:** Private Company
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 1968
- **Assets under management:** Undisclosed
- **Website:** www.dexcel.com
- **LinkedIn:** https://www.linkedin.com/company/dexcel-pharma-technologies

## Regulatory record

- **Reports private funds:** No

## About

Dexcel Pharma Technologies Ltd. operates as a pharmaceutical development and manufacturing company with a stated focus on oral, topical, and injectable products. The firm was originally founded in Israel in 1959, later rebranded and restructured to comprise a network of facilities across the United States, Europe, and Asia. Its global headquarters is now based in New York, with facilities in Cincinnati, Ann Arbor, Shanghai, Larkspur, Spring, and Or Akiva, according to the firm's own communications. The company's strategy encompasses both generic and specialty branded pharmaceuticals, with a particular emphasis on complex dosage forms and drug delivery technologies. Dexcel Pharma Technologies claims capabilities across full-cycle product development, from formulation through clinical trials and commercial manufacturing. Its portfolio includes products targeting therapeutic areas like neurology, gastroenterology, and women's health. The firm also engages in contract development and manufacturing (CDMO) services, working with third-party partners in regulated markets. Dexcel Pharma Technologies maintains a team of several hundred professionals globally, though exact headcount is not publicly disclosed. The firm operates through subsidiaries including Dexcel Pharma USA, LLC, and Dexcel Pharma GmbH, and serves a customer base that includes large pharmaceutical companies, healthcare systems, and government agencies. In recent years, the company has focused on expanding its injectable pipeline and entering new high-barrier generic segments. A key structural differentiator is Dexcel Pharma Technologies' vertically integrated model — it controls manufacturing, development, and regulatory filings in-house, allowing it to compete on speed and cost in both the generic and CDMO markets. The firm is privately held, with ownership structure undisclosed, and operates independently from larger corporate parents.

## Sectors

- Pharmaceuticals
- Healthcare Services

## Offices

- Cincinnati, Ohio, United States
- Ann Arbor, Michigan, United States
- Shanghai, China
- Larkspur, California, United States
- Spring, Texas, United States
- Or Akiva, Israel

## People

- Dexcel Pharma Technologies Ltd. — Company

## Questions

### What is Dexcel Pharma Technologies Ltd.'s core business?

Dexcel Pharma Technologies is a pharmaceutical development and manufacturing company specializing in oral, topical, and injectable dosage forms. It operates as a full-service CDMO and also markets its own branded and generic products globally (per the firm's official communications).

### Where are Dexcel Pharma Technologies Ltd.'s operations located?

The firm has facilities in New York (global HQ), Cincinnati, Ann Arbor, Shanghai, Larkspur, Spring, and Or Akiva. These sites cover R&D, manufacturing, and commercial operations (per the firm's website).

### What therapeutic areas does Dexcel Pharma Technologies Ltd. focus on?

Dexcel Pharma Technologies has disclosed a focus on neurology, gastroenterology, and women's health, among other therapeutic categories (per the firm's own communications).

### Is Dexcel Pharma Technologies Ltd. publicly traded?

No, Dexcel Pharma Technologies Ltd. is privately held. Ownership and capital structure are not publicly disclosed.

### Does Dexcel Pharma Technologies Ltd. have any known subsidiaries?

Yes, the company operates through subsidiaries including Dexcel Pharma USA, LLC and Dexcel Pharma GmbH, among others (per business registrations).

## Related profiles

- [Kriya Therapeutics](https://altss.com/profile/kriya-therapeutics)
- [American Tire Distributors](https://altss.com/profile/american-tire-distributors)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/dexcel-pharma-technologies-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology